» Articles » PMID: 6305226

Current Trends in the Diagnosis and Treatment of Carcinoma of the Pancreas

Overview
Journal Am J Surg
Specialty General Surgery
Date 1983 Jun 1
PMID 6305226
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Causes of diagnostic delay and survival figures were compared in three groups of patients (total 191 patients) with ductal adenocarcinoma of the pancreas between the years 1951 and 1960 and 1971 and 1980. The main causes of delay between onset of symptoms and definitive treatment were patient delay in seeking medical advice and delay by the initial doctor in referring the patient. Recent direct imaging techniques of ultrasound, computerized axial tomographic scanning, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography did not significantly decrease this diagnostic delay. Operative mortality in the groups treated by pancreatoduodenectomy between 1951 and 1960 and 1971 and 1980 were 13.9 and 3.4 percent, respectively. The mean survival rates for these groups were 14 and 20.4 months, respectively. Patients with unresectable carcinoma of the pancreas between 1971 and 1980 had an operative mortality rate of 10 percent and a mean survival of 6.7 months. Various aspects of symptomatology and operative findings in patients with carcinoma of the pancreas are emphasized to aid early diagnosis.

Citing Articles

Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer.

Tiffon C Pancreas. 2018; 47(2):200-207.

PMID: 29303911 PMC: 5777573. DOI: 10.1097/MPA.0000000000000982.


Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer.

Angst E, Sibold S, Tiffon C, Weimann R, Gloor B, Candinas D Br J Cancer. 2006; 95(3):307-13.

PMID: 16832411 PMC: 2360652. DOI: 10.1038/sj.bjc.6603256.


Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel.

Menges M, Pees H Int J Pancreatol. 2000; 26(3):193-9.

PMID: 10732297 DOI: 10.1385/IJGC:26:3:193.


Digestive and nutritional consequences of pancreatic resections. The classical vs the pylorus-sparing procedure.

Crucitti F, Doglietto G, Bellantone R, Miggiano G, Frontera D, Ferrante A Int J Pancreatol. 1995; 17(1):37-45.

PMID: 8568333 DOI: 10.1007/BF02788357.


Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Bakkevold K, Kambestad B Ann Surg. 1993; 217(4):356-68.

PMID: 7682052 PMC: 1242802. DOI: 10.1097/00000658-199304000-00007.